Immunic Inc. (IMUX) Reports FY21 EPS of ($3.93)

Immunic Inc. (NASDAQ: IMUX) reported FY21 EPS of ($3.93). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Alibaba (BABA) PT Lowered to $170 at HSBC
• Goldman Sachs Upgrades Sampo Oyj (SAMPO:FH) (SAXPY) to Buy